Investigation in Progress — No Complaint Filed Yet
BG&G is actively investigating potential securities fraud claims against Rafael Holdings, Inc.. If a complaint is filed, this page will be updated. Investors are encouraged to contact us now to preserve their rights.
Why Is Rafael Holdings, Inc. (RFL) Under Investigation?
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of shareholders of Rafael Holdings, Inc. (NYSE: RFL).
On September 30, 2026, Rafael issued a press release “announc[ing] topline efficacy and safety data from its Cyclo Therapeutics, LLC subsidiary’s pivotal Phase 3 TransportNPC™ study (CTD-TCNPC-301) evaluating Trappsol Cyclo™ (intravenous hydroxypropyl-β-cyclodextrin) in 94 patients diagnosed with Niemann-Pick Disease Type C (NPC).” The press release said that “the result did not achieve statistical significance” on the primary endpoint. Following this news, Rafael’s stock price fell $0.71 per share, or 34.98%, to close at $1.32 per share on September 30, 2026.
What Potential Securities Violations Is BG&G Investigating?
- Whether Rafael Holdings, Inc. and certain of its officers made false or misleading statements regarding the Company's financial condition and business prospects.
- Whether Rafael Holdings, Inc. failed to disclose material adverse information that would have been significant to a reasonable investor.
- Whether the Company's earnings guidance was supported by a reasonable factual basis at the time it was made.
What Should Rafael Holdings, Inc. (RFL) Investors Do?
How Is Rafael Holdings, Inc. (NYSE: RFL) Stock Trading Today?
How Does BG&G Help Investors in Securities Fraud Investigations?
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.
We handle cases on a contingency fee basis — we advance all litigation costs on your behalf. There is no fee unless we are successful.
“Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace.”